India
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1,348.13%
|
March 31, 2024 | USD 0.14 | 3.84% |
|
India |
|
2 |
44.97%
|
March 31, 2024 | USD 1.29 | 2.70% |
|
India |
|
3 |
23.56%
|
March 31, 2024 | USD 6.91 | -0.24% |
|
India |
|
4 |
19.34%
|
March 31, 2024 | USD 32.88 | -0.93% |
|
India |
|
5 |
13.43%
|
March 31, 2024 | USD 9.20 | 2.64% |
|
India |
|
6 |
12.83%
|
March 31, 2024 | USD 9.86 | 2.71% |
|
India |
|
7 |
11.98%
|
March 31, 2024 | USD 8.61 | -1.79% |
|
India |
|
8 |
11.66%
|
March 31, 2024 | USD 20.71 | -0.50% |
|
India |
|
9 |
2.96%
|
March 31, 2024 | USD 0.59 | -0.38% |
|
India |
|
10 |
1.42%
|
March 31, 2024 | USD 11.23 | 1.68% |
|
India |
|
11 |
-19.13%
|
March 31, 2024 | USD 16.75 | 0.23% |
|
India |
|
12 |
-38.91%
|
March 31, 2024 | USD 1.48 | 10.54% |
|
India |
|
13 |
-307.91%
|
March 31, 2024 | USD 1.84 | 1.24% |
|
India |
The Clinical Trials company in India with the highest Return on Equity (ROE) is TAKE Solutions Limited (NSE: TAKE.NS) at 1,348.13%.
The Clinical Trials company in India with the lowest Return on Equity (ROE) is Sun Pharma Advanced Research Company Limited (NSE: SPARC.NS) at -307.91%.
The top 10 Clinical Trials companies in India by Return on Equity (ROE) are TAKE Solutions Limited, Ind-Swift Laboratories Limited, Indegene Limited, Dr. Lal PathLabs Limited, Thyrocare Technologies Limited, Vimta Labs Limited, Syngene International Limited, Metropolis Healthcare Limited, Vineet Laboratories Limited and Jubilant Pharmova Limited.
The bottom 10 Clinical Trials companies in India by Return on Equity (ROE) are Sun Pharma Advanced Research Company Limited, Suven Life Sciences Limited, Glenmark Pharmaceuticals Limited, Jubilant Pharmova Limited, Vineet Laboratories Limited, Metropolis Healthcare Limited, Syngene International Limited, Vimta Labs Limited, Thyrocare Technologies Limited and Dr. Lal PathLabs Limited.